https://www.mdpi.com/2077-0383/12/6/2121
Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast...
Cardiovascular (CV) diseases (CVD) are a major cause of long-term morbidity and mortality affecting life expectancy amongst cancer survivors. In recent years,...
side effects
https://www.mdpi.com/2072-666X/12/11/1337
The Interaction between DNA and Three Intercalating Anthracyclines Using Electrochemical DNA...
The screen-printed electrodes have gained increasing importance due to their advantages, such as robustness, portability, and easy handling. The manuscript...
interactiondnathreeintercalatinganthracyclines
https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1101585/full
Frontiers | Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast...
BackgroundFramingham risk score (FRS) is an effective tool for evaluating the 10-year risk of cardiovascular diseases. However, the sensitivity of FRS for an...
risk factorsframingham scorefrontiers
https://www.acc.org/latest-in-cardiology/clinical-trials/2023/08/08/16/06/stop-ca
Statins to Prevent the Cardiotoxicity of Anthracyclines - American College of Cardiology
Dharam J. Kumbhani, MD, SM, FACC; Amit Saha, MD
american collegestatinspreventcardiotoxicityanthracyclines
https://www.mdpi.com/2072-6694/13/17/4421
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current...
Anthracyclines are among the most active chemotherapies (CT) in breast cancer (BC). However, cardiotoxicity is a risk and peculiar side effect that has been...
strike backliposomal doxorubicinanthracyclinesnonpegylated
https://www.acc.org/Membership/Sections-and-Councils/Cardiovascular-Team-Section/Section-Updates/2020/10/21/00/16/New-Infographic-Illustrates-Management-of-Cardiotoxicity-From-Anthracyclines-and-HER2-Antagonists
New Infographic Illustrates Management of Cardiotoxicity From Anthracyclines and HER2...
newinfographicillustratesmanagementcardiotoxicity